| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-0749.2004.00128.X |
| P698 | PubMed publication ID | 15016307 |
| P50 | author | Frank L. Meyskens, Jr. | Q22006852 |
| P2093 | author name string | Sun Yang | |
| Susan E McNulty | |||
| Dazhi Cen | |||
| Raul del Rosario | |||
| P2860 | cites work | Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability | Q36557754 |
| Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha | Q36560731 | ||
| Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product | Q36563306 | ||
| Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control | Q36580820 | ||
| Akt is a downstream target of NF-kappa B. | Q38288465 | ||
| RelA, p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B. | Q38293301 | ||
| Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. | Q39451375 | ||
| Dual inactivation of RB and p53 pathways in RAS-induced melanomas | Q39458533 | ||
| Distinct functional properties of IkappaB alpha and IkappaB beta | Q40023354 | ||
| RelB cellular regulation and transcriptional activity are regulated by p100. | Q40771390 | ||
| Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation? | Q40789264 | ||
| Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha | Q40881293 | ||
| Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. | Q41074033 | ||
| Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases | Q41103907 | ||
| Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. | Q42830960 | ||
| NF-κB stimulates Akt phosphorylation and gene expression by distinct signaling mechanisms | Q42834687 | ||
| The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells | Q43582866 | ||
| The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1 | Q24293229 | ||
| I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity | Q24318573 | ||
| Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit | Q24554482 | ||
| Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity | Q27860643 | ||
| Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II | Q28143275 | ||
| NF-kappaB regulation in the immune system | Q28205043 | ||
| Duration of nuclear NF-kappaB action regulated by reversible acetylation | Q28215080 | ||
| A novel DNA-binding motif shares structural homology to DNA replication and repair nucleases and polymerases | Q28288139 | ||
| TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB | Q29614706 | ||
| NF-kappa B: ten years after | Q29618566 | ||
| NF-kappaB at the crossroads of life and death | Q29619302 | ||
| Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway | Q30310695 | ||
| Alternative splicing variants of IkappaB beta establish differential NF-kappaB signal responsiveness in human cells | Q33786480 | ||
| Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views | Q33797129 | ||
| Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation | Q34217097 | ||
| RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members | Q34364116 | ||
| Mechanisms by which IkappaB proteins control NF-kappaB activity | Q34789958 | ||
| Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. | Q34816285 | ||
| Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma | Q35144283 | ||
| The INK4a/ARF locus and melanoma | Q35146563 | ||
| IkappaB kinase: beginning, not the end | Q36039922 | ||
| P433 | issue | 2 | |
| P921 | main subject | metastatic melanoma | Q18975855 |
| P304 | page(s) | 173-180 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | Pigment Cell & Melanoma Research | Q762851 |
| P1476 | title | Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies | |
| P478 | volume | 17 |
| Q34400230 | A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology |
| Q40395551 | Activation of the NF-kappaB system in peripheral blood leukocytes from patients with chronic heart failure |
| Q35234721 | Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity |
| Q34104950 | Apurinic/apyrimidinic endonuclease/redox effector factor-1(APE/Ref-1): a unique target for the prevention and treatment of human melanoma |
| Q33725012 | Aspirin and other NSAIDs as chemoprevention agents in melanoma |
| Q27026261 | Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesis |
| Q37636774 | DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo |
| Q64271778 | Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective |
| Q34710990 | Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer |
| Q34985378 | Feasibility of serial biopsies of large dysplastic nevi as a melanoma chemoprevention model |
| Q47613853 | Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC. |
| Q34060387 | Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway |
| Q33842059 | IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. |
| Q38745153 | Melanoma Chemoprevention: Current Status and Future Prospects |
| Q40004019 | Melanosomal damage in normal human melanocytes induced by UVB and metal uptake--a basis for the pro-oxidant state of melanoma |
| Q38885288 | MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma. |
| Q39619870 | Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction |
| Q36989431 | Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanoma |
| Q36416479 | NF-kappaB activation in melanoma |
| Q35916919 | NF-κB as potential target in the treatment of melanoma |
| Q36217015 | Nuclear factor-κB expression is predictive of overall survival in patients with cutaneous melanoma. |
| Q36530303 | Pocket protein function in melanocyte homeostasis and neoplasia |
| Q49575918 | Proteasome Inhibitor Carbobenzoxy-L-Leucyl-L-Leucyl-L-Leucinal (MG132) Enhances Therapeutic Effect of Paclitaxel on Breast Cancer by Inhibiting Nuclear Factor (NF)-κB Signaling |
| Q34695267 | Rac1 activity regulates proliferation of aggressive metastatic melanoma |
| Q33795121 | Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models. |
| Q41834174 | Regulation of MSK1-Mediated NF-κB Activation Upon UVB Irradiation |
| Q36178379 | Role of nuclear factor-kappa B in melanoma |
| Q50640441 | Spitz nevi arising in speckled lentiginous nevus: clinical, histologic, and molecular evaluation of two cases. |
| Q30449201 | Suicidal gene therapy in an NF-κB-controlled tumor environment as monitored by a secreted blood reporter |
| Q36836155 | The double life of RIPK1. |
| Q34287452 | The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα |
| Q36790917 | Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model |
| Q37139268 | UVB-stimulated TNFα release from human melanocyte and melanoma cells is mediated by p38 MAPK |
| Q38965192 | Ursolic Acid and Chronic Disease: An Overview of UA's Effects On Prevention and Treatment of Obesity and Cancer |
| Q37362485 | microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB. |
Search more.